Login

Joseph Chen, CEO of Renren Inc., discusses the Chinese social-networking site's recent $855 million completion. 00:10:00

Share On Facebook Share On Twitter

Joseph Chen and Chen Ji are the CEOs of Renren.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Sibanye-Stillwater CEO Neal Froneman expresses difficulty in finding attractive deals in the battery metal sector amidst heightened market excitement, reflecting on past acquisitions and noting concerns about over-optimistic projections for electric vehic
00:10:00
First Helium: Pioneering Publicly Traded Helium Production
00:10:00
Childhood Memories and Creative Innovation in Global Fashion Collaboration
00:10:00
Huntsville Hospital is a community-based, not-for-profit hospital|David Spillers, chief executive officer of the Huntsville Hospital
00:10:00
The Future of Global Trade in a Changing World
00:10:00
Inside Australia's Leading Spiral Manufacturing Plant: A Showcase of Excellence | Andrew Foster, Managing Director of Mineral Technologies
00:10:00
DCM: David focuses on consumer, fintech, and digital health.|David Cheng,Principal, DCM
00:10:00
Kenex Mines' High-Grade Copper Discoveries and Exploration Plans in Manitoba
00:10:00
invests in and co-builds world-class startups|Mike Janke,Co-Founder & Investment Board Member,DataTribe
00:10:00
Korai Graphite-Vanadium Project: Exceptional Measured Resource in Northern Mozambique
00:10:00
With the US OTCQX launch, Bango PLC hopes to increase liquidity and diversify its investor base | Paul Larbey, CEO, Bango PLCBGO:LSE
00:10:00
The science that protects life| Claus Egstrand,CEO,Enzymatica

© 2017 - Neuhu+